Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP734334.RAi2aIB0luXehhiCRPnkzlj4Ougq6d1JG2FEKPcdT-Gbo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP734334.RAi2aIB0luXehhiCRPnkzlj4Ougq6d1JG2FEKPcdT-Gbo130_assertion type Assertion NP734334.RAi2aIB0luXehhiCRPnkzlj4Ougq6d1JG2FEKPcdT-Gbo130_head.
- NP734334.RAi2aIB0luXehhiCRPnkzlj4Ougq6d1JG2FEKPcdT-Gbo130_assertion description "[In histopathologic examination, TERC was amplified in 28 of 671 (4.2%) normal, inflammatory, or wart cases; in 17 of 233 (7.3%) cervical intraepithelial neoplasia grade 1 cases (CIN 1); in 27 of 39 (69.2%) CIN 2 cases; in 57 of 67 (85.1%) CIN 3 cases; and in 22 of 23 (95.7%) cervical cancer cases; with pairwise significant difference in each (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734334.RAi2aIB0luXehhiCRPnkzlj4Ougq6d1JG2FEKPcdT-Gbo130_provenance.
- NP734334.RAi2aIB0luXehhiCRPnkzlj4Ougq6d1JG2FEKPcdT-Gbo130_assertion evidence source_evidence_literature NP734334.RAi2aIB0luXehhiCRPnkzlj4Ougq6d1JG2FEKPcdT-Gbo130_provenance.
- NP734334.RAi2aIB0luXehhiCRPnkzlj4Ougq6d1JG2FEKPcdT-Gbo130_assertion SIO_000772 19389503 NP734334.RAi2aIB0luXehhiCRPnkzlj4Ougq6d1JG2FEKPcdT-Gbo130_provenance.
- NP734334.RAi2aIB0luXehhiCRPnkzlj4Ougq6d1JG2FEKPcdT-Gbo130_assertion wasDerivedFrom befree-2016 NP734334.RAi2aIB0luXehhiCRPnkzlj4Ougq6d1JG2FEKPcdT-Gbo130_provenance.
- NP734334.RAi2aIB0luXehhiCRPnkzlj4Ougq6d1JG2FEKPcdT-Gbo130_assertion wasGeneratedBy ECO_0000203 NP734334.RAi2aIB0luXehhiCRPnkzlj4Ougq6d1JG2FEKPcdT-Gbo130_provenance.